Longitude Capital Partners V, LLC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-20 9:00 pm Purchase |
2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX |
Longitude Capital Partners V, LLC | 11,538,461 7.300% |
11,538,461 (New Position) |
Filing |